Skip to main content
ConductScienceScienceDex

Tomasz Skorski

NIH Rank #2860
Unclaimed recordClaim profile
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 1874940Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Microbiology & Immunology
  • Internal Medicine

NIH Funding · FY2024

Linked Award Amount
$2.9M
Full award amounts, FY2024
Award Records
6
Records listing this PI
Award-Linked Rank
#2,860
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Tomasz Skorski. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Tomasz Skorski as a PI. Multi-PI records show the full award amount for context.

  • 5R01CA283396-02R01
    Divergent Functions of ERK Substrate Binding Domains in Pathogenesis of Myeloproliferative Neoplasms
    Fox Chase Cancer Center
    $671.7K
    award amount
  • 5R01CA237286-05R01
    AML mutation-guided drugging of DNA repair
    Temple University
    $523.1K
    award amount
  • 5R01CA244179-05R01
    PolQ as a novel therapeutic target in AML
    Temple University
    $499.9K
    award amount
  • 5R01CA247707-05R01
    MPN-inducing mutations as biomarkers of synthetic lethality
    Temple University
    $406.9K
    award amount
  • 5R01CA244044-05R01
    Oncogenic tyrosine kinases inhibitors abrogate DNA repair and sensitive leukemias to PARP inhibitors
    Temple University
    $387.3K
    award amount
  • 5R01CA186238-10R01
    Targeting DNA repair to eradicate TKi-refractory/resistant CML and Ph+ALL
    Temple University
    $377.6K
    award amount

Award organizations

Organizations that administered FY2024 awards listing Tomasz Skorski as a PI.

Temple University
PA
$2.2M
5 grants
Fox Chase Cancer Center
PA
$671.7K
1 grant

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Temple University
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #2860
  6. 2024
    Entered Top 25% Nationally
    Ranked #2860
  7. 2025
    Multi-Institutional Research
    Awards at 2 institutions
  8. 2025
    R01 Grant Holder

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Tomasz Skorski.

David L. Wiest
Fox Chase Cancer Center
3
shared awards
Alexander V Mazin
Temple University
1
shared award
Richard T Pomerantz
Temple University
1
shared award

Explore further

Find collaborators for Tomasz Skorski

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →